Anti-herpes simplex virus activities of crude water extracts of Thai medicinal plants (Q28373156)

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Combined antiviral effects of interferon, adenine, arabinoside, hypoxanthine arabinoside, and adenine arabinoside-5'-monophosphate in human fibroblast cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculat

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. I. Effect on cell growth, virus particles and virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Flow cytometric detection of herpes simplex virus type 2 infected and transformed cells by immunoenzymatic and by indirect immunofluorescence staining

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Efficacy of traditional herbal medicines in combination with acyclovir against herpes simplex virus type 1 infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

The effect of asiaticoside on pig skin in organ culture

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Suppression of infectious virus spread and corneal opacification by the combined use of recombinant interferon beta and interleukin-10 following corneal infection with herpes simplex virus-1 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Infection with herpes-simplex viruses 1 and 2. 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Infection with herpes-simplex viruses 1 and 2. II.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Infection with herpes-simplex viruses 1 and 2. 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

In vitro antiviral activity of dammar resin triterpenoids

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Strategic design and three-dimensional analysis of antiviral drug combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Mechanism of antioxidant action of pueraria glycoside (PG)-1 (an isoflavonoid) and mangiferin (a xanthonoid).

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021

Delayed treatment with combinations of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980068-9

7 January 2021